Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG0302)

Gotoh, M., Takiuchi, H., Imamura, H, Imano, M., Kimura, Y., Ishida, H., Tsujinaka, T., Narahara, T, Furukawa, H. Osaka Gastrointestinal Cancer Chemotherapy Study Group: OGSG: Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG 0302). International Gastric cancer Association

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62